holding up well, page-3

I may have come up with a reason why they need capital

At first, I think Ropren will sell but sell small. Maybe 1000 boxes to St Petersberg.

I think the company is anticipating demand to increase during next year, so they want to produce to full capacity and stock pile the drug.

If they are producing more than they are selling, cash burn is going to be an issue. They are only looking to raise 2M short term which is quite small, so they must be expecting demand to pick up next year.

Next will be 9 or 10 hospitals in Moscow.

Also two they are in with one of the biggest Russian Pharm distributors. That is a good thing.

I still recon 22c is an unreal buy, look back in two years and the thing will be $2